ZNF217 and breast cancer: Although known ‘catalytic’ inhibitors of LSD1 demethylase function exhibit no effect on growth of breast cancer models, we find that an allosteric inhibitor of the LSD1-ZNF217 interaction (SP-2509) recapitulates these phenotypes both in vitro and in vivo.